Dr. Elizabeth Eisenhauer has been named the winner of the 2021 Canada Gairdner Wightman Award. The award is given to a Canadian scientist recognized for outstanding leadership in medicine and medical science throughout their career. Eisenhauer is receiving the award for her transformational research in cancer clinical trials and cancer drug delivery and the impact of her work for patients around the world.
Eisenhauer is Professor Emerita, Departments of Oncology and Medicine, Adjunct Professor of Oncology, Queen’s University and Innovation Lead, Kingston Health Sciences Centre. She is a current member of OICR’s Therapeutics Pipeline Advisory Committee, past Co-chair of OICR’s Scientific Advisory Board and was a founding member of OICR’s Board of Directors.
Eisenhauer has made fundamental contributions to the clinical evaluation of new cancer therapies, research strategy and clinical trials development that have been essential in the development of new treatments for ovarian cancer, malignant melanoma and brain tumours.
OICR congratulates Eisenhauer on this very well-deserved honour and thanks her for her past and current contributions to OICR and leadership in the cancer research community.